<?xml version="1.0" encoding="UTF-8"?>
<p>Until today, the main goal of ATMPs is incurable diseases, orphan diseases and chronic diseases that traditional drugs are unable to treat. In particular, genetic and metabolic diseases, degenerative neurological diseases, malignancies and hematological diseases, serious cardiological and orthopedic cases are the field of their application, whereas their action for the regeneration of damaged tissues is essentially responsible for the rapid development of the field of regenerative medicine (
 <xref ref-type="fig" rid="F1">Fig. 1</xref>) [
 <xref rid="R05" ref-type="bibr">5</xref>].
</p>
